Showing results (131-140 of 517) with videos related to

Sort By:
Pageof 52
The American Journal of Cardiology|August 2, 2005
Impact of failed mechanical reperfusion in patients with acute myocardial infarction treated with primary angioplastyNicolette M S K J Ernst, Jorik R Timmer, Felix Zijlstra, et al.
International Journal of Cardiology|September 28, 2023
Immediate versus staged complete revascularization in acute coronary syndrome: A meta-analysis of randomized controlled trialsKamil Bujak, Riccardo Rinaldi, Pablo Vidal-Cales, et al.
Medical Devices (Auckland, N.Z.)|May 11, 2013
Bioresorbable scaffolds in the treatment of coronary artery diseaseYaojun Zhang, Christos V Bourantas, Vasim Farooq, et al.
Frontiers in Cardiovascular Medicine|April 20, 2023
Influence of chronic kidney disease and other risk factors pre-heart transplantation on malignancy incidence post-heart transplantationStefan Roest, Muhammed T Gürgöze, Wida S Cherikh, et al.
JACC. Cardiovascular Interventions|March 20, 2010
Mortality and morbidity reduction by primary percutaneous coronary intervention is independent of the patient's ageSanneke P M de Boer, Cynthia M Westerhout, R John Simes, et al.
Kardiologia Polska|April 1, 2026
Immediate versus staged complete revascularization using drug-eluting stents in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: An updated meta-analysis after the OPTION-STEMI trialGianluca Di Pietro, Riccardo Improta, Ovidio De Filippo, et al.
American Heart Journal|January 31, 2006
Glucose-insulin-potassium infusion in acute myocardial infarction: a hemodynamic studyArend Bergstra, Tone Svilaas, Ad F M van den Heuvel, et al.
International Journal of Cardiology|October 26, 2005
Long-term follow-up after invasive approach of coronary artery disease in daily practiceArno Breeman, Jorik Timmer, Jan Paul Ottervanger, et al.
European Heart Journal|February 27, 2015
Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trialFrancesco Costa, Pascal Vranckx, Sergio Leonardi, et al.
Cardiovascular Diabetology|July 29, 2009
The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitusChris P H Lexis, Braim M Rahel, Joan G Meeder, et al.
Pageof 52